ArticleBriefings in bioinformatics2026
CONTRA-IL6: an interpretable hybrid convolutional neural network and Transformer framework for accurate prediction of interleukin-6-inducing peptides using protein language models.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PhoSARte: identification of SARS-CoV-2 phosphorylation sites using contrastive learning and protein language models.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Interleukin-6 (IL-6) is a key immunomodulatory cytokine implicated in diverse physiological processes and pathological conditions, including autoimmune diseases, cancers, and cytokine storms. Immunogenic peptides capable of inducing IL-6 expression are key modulators of host immune responses and represent promising candidates for therapeutic design and epitope-based vaccine development. However, experimental identification of IL-6-inducing peptides remains laborious and unsuitable for large-scale screening. Although existing computational approaches show promise, many often struggle to capture both global contextual semantics and local motif-level features essential for peptide immunogenicity. To address these limitations, we present CONTRA-IL6, a novel deep learning framework that integrates Transformer fusion and convolutional localization modules with stacked pretrained protein language model embeddings to predict IL-6-inducing peptides. Comprehensive benchmarking on an independent dataset demonstrates that CONTRA-IL6 achieves superior predictive performance over six state-of-the-art predictors. Notably, it achieves the highest Matthews correlation coefficient (MCC, 0.504) and F1 (0.549) and improves over the best-performing existing method by 3.2% in MCC and 4.3% in F1, demonstrating balanced and robust performance. Feature space visualizations (uniform manifold approximation and projection, kernel density estimation) showed clear class separation, while 1D gradient-weighted class activation mapping++ highlighted strong attention to specific C-terminal regions. Crucially, we moved beyond these attribution methods by employing in silico mutagenesis, which causally confirmed the functional importance and physicochemical constraints. Ablation studies further confirmed the synergistic contribution of global and local modules to model performance. CONTRA-IL6 offers a robust, scalable, and interpretable solution for immunoinformatics research. The standalone package is freely available at https://pypi.org/project/contra-il6/ to facilitate broader community use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.